Medline targets $5.37bn in landmark IPO

Medline, an Illinois-based medical supply company, is planning an initial public offering (IPO) to raise up to $5.37 billion, potentially valuing the company at approximately $55 billion. The IPO is expected to be priced on December 16 and involves offering 179 million shares on Nasdaq with a price range of $26 to $30 per share, making it one of the largest US healthcare listings on record.